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Keywords: cartilage hyaluronan chondroprogenitors transglutaminase bioadhesive 
In this study transglutaminase-crosslinked hyaluronan hydrogels (HA-TG) are investigated for 
their potential treating cartilage lesions. We show the hydrogels fulfill key requirements: they are 
simultaneously injectable, fast-gelling, biocompatible with encapsulated cells, mitogenic, 
chondroinductive, form-stable and strongly adhesive to native cartilage. Human 
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chondroprogenitors encapsulated in HA-TG gels simultaneously show good growth and 
chondrogenesis. Strikingly, within soft gels (~1 kPa), chondroprogenitors proliferate and deposit 
extracellular matrix to the extent that the hydrogels reach a modulus (~0.3 MPa) approaching 
that of native cartilage (~1 MPa) within 3 weeks. The combination of such off-the-shelf human 
chondroprogenitor cell line with HA-TG hydrogels lay the foundation for a cell-based treatment 
for cartilage lesions which is based on a minimally invasive one-step procedure, with improved 
reproducibility due to the defined cells, and with improved integration with the surrounding 
tissue due to the new hydrogel chemistry.  
1. Introduction 
Cartilage tissue has limited self-repair ability after injury or disease, which has prompted 
intensive efforts to engineer cell-based methods to regenerate the tissue.
1
 In particular, matrix 
assisted autologous chondrocyte implantation (MACI) has been shown to be effective in 
comparison to microfracture,
2
 but significant limitations and costs associated with cell expansion 
and two surgeries have prompted the search towards alternatives.
3
 Single step procedures have 
been applied as early as 1982, when Albrecht and colleagues used autologous particulate 
cartilage pieces to treat articular joint surface defects.
4
 This technique matured into a clinical 
product in the early 2000’s with the introduction of cartilage autograft implantation system 
(CAIS) showing satisfying 2-year safety data.
5
 Varying follow-up papers have shown general 
feasibility of minced autologous and allogeneic living cartilage pieces, with Christensen 
reporting 2-year data among a small collective of patients that have been treated with particulate 
cartilage pieces fixed by fibrin glue.
6
 Clinical and MRI data showed good patient satisfaction and 
morphologically robust cartilage tissue formation.  
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Other approaches to further advance the treatment of cartilage lesions include development of 
injectable materials which can undergo in situ polymerization. GelrinC, based on polyethylene 
glycol (PEG) diacrylate and fibrinogen,
7
 as well as the chitosan-based BS-Cargel are acellular 
products designed to enhance outcome of microfracture by providing a 3D environment for the 
repair cells.
8
 Other injectable systems such as those based on albumin, hyaluronan (HA) and 
PEG (Novocart Inject 
9
) are designed to be combined with autologous expanded chondrocytes. In 
addition the use of juvenile cartilage cells, considered immune-privileged and with great 
regenerative potential, has recently entered phase II clinical trials with promising results 
(RevaFlex
TM
). In each clinical setting, an injectable material which is adhesive, chondrogenic 
and mitogenic is desired.
10
 We recently reported the synthesis of novel HA-based injectable 
hydrogels which use the specific transglutaminase (TG) activity of the activated blood 
coagulation factor XIII (FXIIIa) for crosslinking.
11
 The improved biocompatibility, gelling 
kinetics and adhesion due to this cross-linking scheme
12
 are particularly attractive for cell 
delivery in cartilage applications. Furthermore, HA is a prominent component of cartilage tissue 
and is involved in many biological interactions (such as aggrecan binding to form large 
aggregates important for load bearing
13
) and signaling (through receptors such as CD44). Our 
synthesis is additionally based on high molecular weight HA which has been documented as 
anti-angiogenic, anti-oxidant and anti-inflammatory.
14
  
In this paper, the HA-TG hydrogel is combined with human chondroprogenitor cells (hCCs) 
which were isolated by outgrowth culture from a 14 week fetal ulnar epiphysis. These cells have 
previously been shown to exhibit great homogeneity in expansion with steady proliferative 
potential
15
 and produce phenotypically stable cartilage resistant to vascularization and 
mineralization in an in vivo subcutaneous mouse model.
16
 hCCs also have low immunogenicity 
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which makes them appropriate as an allogeneic off-the-shelf cell source where many patients can 
be treated in single step procedures from the same cell line.  
2. Results and discussion 
2.1. Material synthesis 
To impart FXIIIa sensitivity to HA, we substituted the polysaccharide with a spacer followed by 
peptides which are specifically recognized and covalently ligated by the enzyme. One of the 
peptides donates the reactive lysine (TG/Lys) and the other the reactive glutamine (TG/Gln). HA 
substituted with TG/Gln and TG/Lys are synthesized separately, and then combined in equimolar 
amounts together with the enzyme to trigger the gelation, which can be done directly into 
cartilage defects and with encapsulated cells, as illustrated in Figure 1. The HA starting material 
as well as FXIII and thrombin are all in widespread use in the clinics, making it unlikely that any 
of the gel derivatives could create an immune response.
17
 The fast and mild gelation makes the 
material particularly adapted to injection in situ, which would be optimum for clinical 
translation. For example, the gelling time for 1% (w/v) gels with 10 U/ml FXIIIa is on the order 
of ~30 s (time during which the precursor solution can be pipetted up and down after adding the 
enzyme until it forms a gel strong enough to clog the pipette) and no side reactions occur which 
could lead to toxicity due to the specificity of the enzyme. 
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Figure 1. Concept schematics showing the gelation mechanism of transglutaminase (TG) cross-
linked hyaluronan (HA). The lysine and glutamine residues that are covalently cross-linked by 
the TG FXIIIa are highlighted on the left, and the amide bond resulting from the conjugation is 
shown on the right. HA chains appear in black, peptides in red with reactive side chains 
explicitly shown, and the spacer/adapter between the peptides and the HA is in purple. 
Encapsulated human chondroprogenitor cells (hCCs) and adhesion to cartilage tissue are also 
represented.  
The synthesis of the HA-TG precursors has been described in detail previously.
11
 In short, HA 
was first thiolated using EDC activation and hydrazide conjugation of a dithiol containing 
compound, followed by reduction of the dithiol with TCEP to yield HA-SH (Figure 2, Step 1). 
Then, a large excess of divinyl sulfone was added, to exchange the thiol functionality to vinyl 
sulfones (VS), yielding HA-VS. Finally, peptides containing a cysteine cassette were reacted 
onto the HA-VS, using again the efficiency of the Michael addition of thiols on VS (Figure 2, 
step 3). At every step, dialysis was the method of choice for removal of the buffers and unreacted 
small molecules, because it is very efficient with polymers and ensures no stress on the high MW 
HA chains, preserving the molecular weight.  
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Figure 2. Chemical synthesis of HA-TG precursors. Reaction conditions are 1/ EDC, MES 
pH4.1 to 4.5, DTPHY then TCEP, 2/ DVS, TEOA pH8, 3/ Peptide, TEOA pH8. 
To make gels with MMP sensitivity, we made a version of HA-TG that incorporated an MMP 
cleavable sequence within the TG/Lys peptide (Figure 2). 
In this procedure, we targeted (through the amount of reagents in the first step) a substitution 
rate of 10%, which was confirmed by proton NMR on the HA-VS in D2O as shown previously 
(VS peaks between 6 and 7 ppm versus acetylate peak from HA backbone at 1.9 ppm). Complete 
substitution of the HA-VS with peptides was confirmed by the complete disappearance of the VS 
peaks.  
Since high molecular weight polymers and viscous solutions are difficult to analyze in details 
by NMR due to peak broadening, and since the HA-TG is an extreme case of such a solution, we 
treated the HA-TG precursor HA-TG/Lys with hyaluronidase at 10 U/ml overnight at 37ºC to 
partially hydrolyze the polysaccharide backbone and get clear NMR spectra. Reference spectra 
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of unmodified HA, TG/Lys and DTPHY were used for peak identification, as well as previously 
published work on HA proton and carbon NMR.
18
 To assign the peaks (especially on TG/Lys, 
for which no reference was known), the neighbours in the COSY spectrum together with 
multiplicity and integrals from the 1H spectrum were used. HSQC spectrum helped to 
distinguish overlapping peaks and was used to assign the carbons in the 13C spectrum. New 
peaks in the conjugate and cysteine beta-carbon shift show the creation of the linker and confirm 
the chemical structure (Supplementary Figures 7-10).  
 
2.2. Mechanical characterization 
The gelling behavior was characterized by rheometry (Figure 3A-B). Instead of pre-activating 
FXIII with thrombin as was done in the PEG literature, we reasoned that in situ activation of 
FXIII would give more interesting gelling kinetics. This way, a quite high amount of FXIII can 
be used, for very fast equilibration after activation, and the initial gelling speed can be tuned with 
the amount of thrombin, to have the gelling onset at the desired time (this can be seen as a cross-
linking method having second order kinetics versus time instead of the usual linear progression). 
It also means the same enzyme concentrations can be used for any macromer content, always 
yielding a similar gelation onset time. We chose to use 20 U/ml of FXIII and 12.5 U/ml of 
thrombin to obtain a gelation onset at around 1 min and an equilibration to a plateau after 10 
min. In comparison, typical PEG gels formed by Michael addition typically have an onset of >10 
min and equilibration in >1h at physiological pH.
19
 The very high number of functional groups 
present on a single molecule, due to the high molecular weight of the HA precursor and 10% 
substitution rate, is expected to contribute largely to the fast gelation, together with the good 
kinetics of FXIIIa catalyzed cross-linking in general.  
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Figure 3. Material properties. (A) Representative gelling curves as monitored by rheometry 
showing the build-up of the storage G′ and loss G″ moduli for various concentrations of HA-TG. 
Note the fast gelation and equilibration to a plateau. (B) Values of the final storage modulus 
(taken at 30 min), showing the range of stiffness used in this study and the absence of influence 
from MMP sensitive sequence addition. (C) Change in diameter of the gels after 4 days of 
swelling in PBS. The dotted line indicates no change. (D) Swelling ratio (wet/dry weight of the 
gels) after 4 days of swelling in PBS. The dotted line indicates the values expected for no mass 
loss or volume change. Error bars: SD with n=8 (for C and D at 3%) or n=3 (the rest).  
Macromer precursor solutions of 1 to 3% gave storage moduli ranging from ~ 0.3 to 2 kPa, 
which span a range of stiffness that supported high cell viability. 
19
 Stable gels could still be 
formed down to at least 0.25% (w/v), but the high viscosity of the solutions at more than 3% 
makes the handling of more concentrated precursors difficult. There was no difference in 
mechanical properties of the HA-TG gel due to inclusion of the MMP-sensitive peptide. 
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Complete degradation of the gels could be achieved by treating them with either 10 U/ml 
hyaluronidase in PBS overnight at 37ºC, or 0.25% trypsin for 15 min at 37ºC. This indicates 
biodegradation is not hindered by TG cross-linking. The cells were nevertheless stable when 
used for cell cultures, as shown in the following sections.  
Measurement of gel diameter and swelling ratios (dry mass over wet mass) showed that the 
gels did not undergo any dimensional change or polymer loss compared to D0 cast gels after 
incubation in PBS for 4 days (Figure 3C-D). The stable polymer content over 4 days 
demonstrates that essentially all HA chains were cross-linked, something which was expected for 
such a high number of functional groups per polymer chain. The lack of swelling or shrinkage, 
however, was a remarkable finding as it indicates a perfect balance of attraction and repulsion 
between the chains which allowed the gels to maintain their size at each concentration examined. 
Every part of the polymer chain likely plays a role in the auspicious shape stability, with 
negative charge on the HA contributing repulsion, peptides contributing positive charges, and the 
spacers hydrophobicity. As a partial confirmation of this reasoning, we measured the change in 
the diameter of HA-TG 1% gel disks when the ionic strength of the buffer is altered, which 
essentially changes the extent of shielding of the negative charge on the chains (Supplementary 
Figure 4). As expected, gels immersed in ultrapure water increased in size while gels immersed 
in brine were shrinking (by approximately 200% and 10% respectively). The shape stability of 
HA-TG in physiological conditions is in contrast to most hydrogel systems where chain-chain 
and chain-solvent interactions lead to significant gel shrinkage or swelling. In these cases the 
unpredictable concentration- and time-dependent shape change can cause tissue engineered 
constructs to delaminate or pop out from their site of implantation.  
2.3. Adhesion to cartilage explants 
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Figure 4. Adhesion to cartilage. (A) Cartilage biopsies adhered together with a gel layer. (B) 
Setup of the push-out assay for bond strength determination. (C) Bond strength of HA-TG gels 
compared with alginate and fibrin. Brackets: p<0.05. Error bars: SEM n=6.  
Adhesion to cartilage explants was studied with push-out tests of cylinders of gels made in 4 
mm rings of bovine cartilage (Figure 4). The adhesion was compared to fibrin, a common 
surgical glue and sealant,
20
 and alginate, which is the most common hydrogel for 3D 
chondrocyte culture but is not adhesive.
21
 The HA-TG was found to be significantly more 
adhesive to cartilage than fibrin glue, which was itself more adhesive than alginate (student t-
tests p<0.05). When the cartilage surface was treated with chondroitinase, to remove the 
polysaccharides and expose the protein part of the cartilage matrix, which is what mediates the 
adhesion in all three cases, the adhesion strength was found to be increased by approximately 2, 
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3, and 6 fold for fibrin, HA-TG, and alginate respectively. Alginate and fibrin were becoming 
comparable, but HA-TG adhesion was ~3 times stronger than the controls, reaching a bond 
strength of more than 6 kPa.  
 
2.4. Cartilage formation from encapsulated hCCs 
Finally, hCCs were encapsulated in the hydrogels to study their potential to support 
chondrogenesis and effective cartilage tissue formation. These cells are particularly appealing for 
clinical translation due to their high chondrogenic potential and ability to treat many patients in a 
reproducible manner. They do not constitutively express cell surface molecules required for 
induction of T cell immune responses, and they were shown not to stimulate allogeneic T cells in 
vitro.
22
  We analyzed the biological and mechanical outcome of hCCs in HA-TG cultures at 3 
weeks post-encapsulation (D21). Alginate gels were used as controls.  
Live/dead assays showed nearly full viability in all conditions (Figure 5A), and cell 
morphology as seen from calcein (whole cell) and actin staining (Figure 5B) was strongly 
dependent on polymer concentration. Cells spread and proliferated to fill almost the whole space 
in the softest gels, whereas they only formed small clusters without spreading in the stronger 
gels. Confocal imaging of fluorescein tagged HA-TG gels (Supplementary Figure 5) showed that 
the pore size was under the resolution limit (~200 nm) in all conditions. The differences in cell 
spreading are therefore not directly explained by gel porosity, and have to involve gel 
deformation or degradation. Second harmonic generation (SHG) at 60 micron depth from the 
surface was collected simultaneously with calcein/PI fluorescence. This provided a way to check 
overall collagen production in a non-type-specific way directly amongst the living cells. The soft 
gels clearly stood out from the rest for being completely filled with a dense collagen network, 
whereas the other conditions just showed collagen deposition pericellularly. The collagen 
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appeared fibrillar on the very surface of the gel, which is commonly seen from collagen 1 
staining of such engineered cartilage constructs, but more homogeneous inside the gel, though it 
is deposited in the shape of the spread cells.  
 
Figure 5. Cell and collagen morphology visualized with non-specific markers. (A) Multiphoton 
live imaging, with simultaneous acquisition of calcein (cytoplasm of live cells, green), propidium 
iodide (PI, nuclei of dead cells, red), and second harmonic generation (SHG, assembled collagen, 
blue). All conditions are highly viable, while cells spread, proliferate, and deposit a dense 
collagen matrix in soft HA-TG gels only. Images are aquired at ~60 µm depth beneath the 
surface of the gels. (B) Actin cytoskeleton (phalloidin, red) and nuclei (DAPI, blue) imaged in 
the center of the gels from fixed cryosections. This highlights that the spreading and proliferation 
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of hCCs in soft HA-TG gels are not merely surface effects. (A+B) Images are at 21 days post 
encapsulation. Scale bars: 80 µm.  
 
Figure 6. Cartilage production by encapsulated hCCs as seen from (A) gene expression 21 days 
post encapsulation, normalized to expression on the day of encapsulation (D0), and (B) matrix 
protein deposition. Each image is from a vertical slice of the gel taken from the center of the 
cylinder. Collagen 1, collagen 2 and DAPI are acquired on the same section. Scale bars: 400 µm.  
We then investigated the matrix deposition at the gene and protein level with qPCR normalized 
to D0 and immunofluorescence, respectively (Figure 6). In all conditions, collagen 2 gene 
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expression increased at least 10
4 
fold, whereas collagen 1 upregulation was less than 10 fold, 
indicating good induction of chondrogenesis in all conditions. The high collagen 2 expression 
was also translated to the protein level: the soft gels were entirely filled with collagen 2 matrix, 
whereas the stiffer gels had only thin and more compact collagen 2 deposition around the cell 
clusters, reminiscent of what was seen in SHG. The collagen 2 / collagen 1 ratio was slightly 
higher in stiffer gels, which was expected as these cells had a rounder cell morphology.
23
 
Aggrecan was upregulated on the order of 10 fold in all conditions, again with higher expression 
in the stiffer gels. Aggrecan deposition was particularly strong on the HA gels surface. The most 
striking difference between the conditions is that the matrix deposition is more pericellular in 
stiffer gels and more homogeneous in softer gels. 
The pattern of protein deposition was strongly depth-dependent, which can be attributed to that 
fact that the hydrogels were cultured in cylindrical PDMS casters bound to coverslips.  The 
stainings clearly show proximity to the surface strongly benefits protein production, probably 
due to better access to nutrients/growth factors.  
Finally, the most important outcome for clinical applications, the evolution of the mechanical 
properties over time, was evaluated (Figure 7). While it was found that stiff 3% gels essentially 
maintain their stiffness over the 3 week culture period, soft 1% gels showed a tremendous 
increase in stiffness from an initial compressive modulus of ~1 kPa to a final value close to 0.3 
MPa. Native cartilage measured in the same conditions was found to be ~1 MPa, consistent with 
reported literature values.
24
 It is particularly noteworthy that the stiffness of the soft gels reached 
the order of magnitude of native cartilage in a clinically-relevant time frame. Intermediate 2% 
gels had values between these two extremes, and alginate gels were too unstable to be measured 
at D0 and only reached 10 kPa at D21. It is important to note that while the alginate gels 
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underwent significant shrinkage and shape change, all of the HA-TG gels had nearly perfectly 
stable shape and size over the culture time. These stiffness results strongly correlate with the 
collagen deposition as seen by SHG that only shows assembled matrix, whereas gene expression 
was not the best predictor of physical outcome.  
 
Figure 7. Evolution of the mechanical properties with matrix deposition by the hCCs between 2 
and 21 days after encapsulation. Bovine hyaline cartilage was found to have a compressive 
modulus of 10
6
 Pa in the same measuring conditions. Error bars: SD from n=3 (D2) and n=6 
(D21).  
All the cell experiments were performed as well with MMP sensitive HA-TG gels, and none of 
the characterizations showed a significant difference between MMP sensitive and insensitive 
gels (data shown in Supplementary Figures 1-3). These results suggest that the increased cost 
and risk of premature gel degradation when using MMP sequences is not warranted, and that the 
use of HA-TG without MMP sequences is the best choice for cartilage tissue engineering. 
Other HA based hydrogels have been described, such as those cross-linked with 
tyramines/HRP/hydrogen peroxide25, methacrylates26, aldehydes, thiols, and Huisgen 
cycloaddition, and have been reviewed27. In particular, photo-crosslinked HA hydrogels were 
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shown to support chondrocyte matrix deposition and chondrogenic differentiation of 
mesenchymal stem cells (MSCs) both in vitro and in vivo. In direct comparison to relatively inert 
poly(ethylene glycol) (PEG) hydrogels, with matched stiffness and same cross-linking chemistry, 
HA supported enhanced expression of cartilage-specific markers. The gene expression and 
matrix deposition found in methacrylated HA was close to what we obtain with 
chondroprogenitors in stiff HA-TG gels, however the authors did not investigate softer 
hydrogels, which give better results in our case, or the stiffening of the gels overtime due to 
matrix deposition.26 Also, all of those cross-linking schemes have at least one drawback 
compared to the one presented here, in terms of specificity/toxicity, of gelling kinetics, of 
stability of the precursors in particular when working with high molecular weight HA, of 
adhesion to cartilage, or of ease of handling and injectability. Other enzymatically cross-linked 
hydrogels have been described as well
28
 some of them enabling fast gel formation, low toxicity 
and adhesion to cartilage, but the amount of matrix deposition and the resulting gel stiffening 
observed in our system are still outstanding. For example, some recent work was published 
showing chondrocyte encapsulation in injectable carboxymethylated pullulan-chondroitin sulfate 
hydrogels. Fast gelling and good cell viability were demonstrated, but collagen 2 upregulation 
compared to 2D cultures, cartilage, or any other reference was not shown, collagen 2 deposition 
was only pericellular, and no gel stiffening resulting from matrix deposition was reported.29  
 
3. Conclusion 
We investigated the use of HA derivatives that can be cross-linked with the transglutaminase 
activity of FXIIIa for cartilage tissue engineering. We showed these gels have an ideal set of 
properties for treating cartilage lesions: they are injectable, very fast gelling, adhesive to 
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cartilage tissue, retain their shape and have excellent biocompatibility. Human 
chondroprogenitors encapsulated in the gels showed tunable proliferation and good cartilage 
matrix deposition, transforming the gels into cartilage-like tissue within three weeks. Strikingly, 
the softest 1% gels showed a tremendous increase in stiffness over the culture time, reaching a 
stiffness of the same order of magnitude as native cartilage. The material development and in 
vitro characterization presented here support that HA-TG has potential for clinical translation, 
which would provide a 1-step treatment simpler than current standards, and should be brought 
forward to in vivo evaluation.  
 
4. Experimental Section 
All chemicals were purchased from Sigma-Aldrich and cell culture reagents from 
ThermoFisher Scientific unless stated otherwise. 
HA-SH synthesis: 400 mg (1 mmol of the disaccharide repeat unit) of HA sodium salt 
(Lifecore Biomedical, 1.01-1.8 MDa), and 23.8 mg (0.1 mmol) of 3,3'-dithiobis(propanoic 
dihydrazide) (DTPHY, Frontier Scientific) were dissolved in a 150 mM MES solution with 
occasional gentle swirling (final pH 4.1). Then 38.4 mg (0.2 mmol) of 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide (EDC, Fluka) was dissolved in 1 ml of deionized water and 
added dropwise with stirring. The stirring was stopped and the reaction was allowed to continue 
overnight. The pH increased towards ~4.5 during the course of the reaction, with MES buffer 
preventing it from going higher. Then, 143.33 mg (0.5 mmol) of TCEP-HCl (Fluorochem) was 
dissolved in 500 µl water and added, the solution was homogenized by swirling, and the 
reduction was left to proceed overnight in a standing sealed flask. Finally, 1 g (17 mmol) of 
NaCl was added to the solution, and the mixture was dialyzed against ultrapure water balanced to 
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pH 4.5 with dilute HCl, with 4 water changes over 24h, to yield a solution of pure HA-SH 
sodium salt. 
HA-VS synthesis: The HA-SH solution recovered from the previous dialysis was added 
dropwise into a solution of 1 ml (10 mmol) divinyl sulfone (DVS) in 40 ml of triethanolamine 
(TEOA) buffer, 300 mM, pH 8.0. The reaction was left to proceed for 2h at RT, then 1 g of NaCl 
was added and the solution was dialyzed against ultrapure water to yield pure vinyl sulfone-
substituted HA (HA-VS). The substitution rate was measured by comparing the peaks at 6.75 
ppm (vinyl sulfones) and 1.75 ppm (N-acetyls from HA) from proton NMR in D2O and found to 
be 10% of the carboxylic acids on HA. 
HA-TG/Lys and HA-TG/Gln: The HA-VS was split in two equal parts. One half was 
substituted with a FXIIIa substrate peptide that provides a reactive glutamine residue (TG/Gln: 
NQEQVSPL-ERCG) and the other half with the peptide providing the reactive lysine (TG/Lys: 
FKGG -ERCG). For a matrix metallo-proteinase (MMP) sensitive version of the gels, a lysine 
donor with an MMP-sensitive sequence 
30
 was used instead (MMP-TG/Lys: FKGG-
GPQGIWGQ-ERCG). Peptides (Anawa) contained ~40% salt which was taken into account in 
the molarity calculations. For conjugation, 10 ml of TEOA buffer 300 mM, pH 8.0 was added to 
each HA-VS portion, the solutions were deoxygenated by bubbling with nitrogen gas, and finally 
the peptides were added at 1.3 excess over the VS. The solutions were quickly homogenized, the 
flasks sealed, and the reactions left to proceed overnight without stirring. Finally, 2 g of NaCl 
were dissolved in each flask, and the products were dialyzed against ultrapure water. The 
resulting pure HA-TG components were sterilized by 0.4 µm filtration, aliquoted, and 
lyophilized under sterile conditions. NMR spectra were acquired on a Bruker 600 Mhz 
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instrument, using 15 to 25 mg of compound in 0.6 ml deuterated water, and spectra were 
analyzed using MestReNova.  
HA-TG gel formation: Aliquots of HA-TG/Lys and HA-TG/Gln were resuspended at 1, 2, or 
3% (w/v) in sterile filtered TBS (NaCl 150mM, CaCl2 50 mM, TRIS 50 mM, balanced to pH 
7.6). Then, the two solutions were combined in equal volume to form HA-TG polymer stock. To 
trigger the gelation of 60 µl of HA-TG solution, 1.5 µl of thrombin solution (Baxter, 500 U/ml) 
followed by 6 µl of FXIII solution (Fibrogammin, CSL Behring, 200 U/ml) were added. Gelation 
occurred in ~1 min, which left enough time to transfer the liquid precursor.  
Alginate gel formation: Alginate (Novamatrix) at 0.33% (w/v) (matching the stiffness of 3% 
HA-TG gels) in NaCl 150mM was placed in 4 mm diameter – 1 mm height cylindrical PDMS 
casters on coverslips, and gelled in  ~500 µl of 100 mM CaCl2 solution for 1h, diffused through 
a pre-wetted membrane. The membrane and calcium were then removed and the gel covered 
with culture medium.  
Shear moduli measurements: After adding the FXIII and thrombin, the gel precursor was 
quickly loaded onto an Anton Paar MCR 301 rheometer equipped with a 20 mm plate-plate 
geometry and metal floor, pre-warmed to 37°C and with humidified chamber. The probe was 
quickly lowered to measuring position (0.1 to 0.2 mm, monitoring the gel precursor forming a 
ring around the geometry while lowering the probe to ensure the measuring space is precisely 
filled). The gelation was then monitored at 1 Hz with 4% strain, which was within the linear 
viscoelastic range of the gels (Supplementary Figure 6). 
Compressive modulus measurements: Gels were left to swell for at least 2 days in PBS and 
tested under unconfined compression using a TA.XTplus Texture Analyzer (Stable 
Microsystems) with a 500 g load cell. The samples were compressed to a final strain of 10% at a 
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rate of 0.01 mm/s. The compressive modulus E reported is the slope of the initial linear range of 
the stress-strain curve. 
Adhesion strength measurements: Bovine articular cartilage samples with 1-2 mm thickness 
were harvested from the knee joints of calves aged 3-6 months. Cartilage rings of 8 mm in outer 
diameter and 4 mm inner diameter were prepared using biopsy punches and washed in PBS. The 
explants were then randomly divided in two groups: one group was left in PBS while the other 
was incubated for 15 minutes at 37°C in 1 U/ml chondroitinase ABC followed by 3 washes with 
PBS. The chondroitinase digestion results in approximately 50 µm digestion of GAGs as 
confirmed by Alcian blue staining (data not shown). Gels were injected into the circular hold of 
the cartilage explants and left to gel for 20 minutes at 37°C in a humidified chamber. To prevent 
leakage the explants were laid on a parafilm-coated surface. HA-TG gels were made as described 
at 3% (w/v), alginate gels at 1.5% (w/v) and gelled by immersion for 1h in a 100 mM calcium 
chloride solution, and fibrin gels contained 2% (w/v) fibrinogen and were gelled with 1 U/ml of 
thrombin for 1h at 37ºC.  Push-out tests were performed at 0.5 mm/s rate with a 3 mm rod. The 
bond strength was calculated as the maximum force divided by the area of the inner punched 
hole.  
hCCs isolation and expansion protocol: hCCs were harvested and isolated as described by 
Darwiche et al. Briefly, a tissue biopsy from the proximal ulnar epiphysis of a 14-week gestation 
donor was taken and minced. hCCs grew out of the tissue pieces. Cells were cultured for up to 2 
weeks in DMEM (cat. 41966) containing 10% v/v FBS, 2mM L-glutamine, and 10 µg/ml 
Gentamycin. The cells were stored in liquid nitrogen, and expanded to passage 3 before 
encapsulation. 
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hCCs encapsulation in gels: Cells were trypsinized and resuspended at 15x106 cells/ml in the 
HA-TG solution, then the gelation was triggered as described previously. The gels were quickly 
cast in 4 mm diameter UV-sterilized PDMS cylindrical molds (SYLGARD 184, Corning) 
adhered to 10 mm coverslips. The gels were allowed to crosslink for 15 minutes at 37°C before 
adding chondrogenic medium (DMEM (cat. 31966) supplemented with 10 ng/ml transforming 
growth factor β3 (TGF-β3, Peprotech), 100 nM dexamethasone, 50 µg/ml L-ascorbate-2-
phosphate, 40 µg/ml proline, 1% penicillin-streptomycin, and 1% ITS+ Premix (Corning)). The 
gels were incubated in a controlled humidified chamber (37°C, 5% (vol/vol)  CO2) for 3 weeks 
and the culture media was replaced twice a week. 
Live imaging: Gels were incubated for 1h in medium supplemented with 2 µM calcein AM and 
6.6 µg/ml propidium iodide (PI), washed with fresh medium, and imaged on a Leica SP8 
multiphoton microscope (25x water immersion objective, Mai Tai irradiation at 900 nm) with 
simultaneous collection of second harmonic generation (SHG) and fluorescence. The pictures 
presented were taken 60 to 70 µm from the sample surface, as the signal deteriorated at deeper 
depths. 
Immunohistochemistry: Gels were fixed in 4% formaldehyde for 45 minutes, embedded in 
O.C.T (Tissue-Tek O.C.T Compound Blue, Sysmex) and stored at -80 °C. 5 µm thick sections 
were cut using a Cryostat (CryoStar NX70, Thermo Scientific). Collagen 1 and 2 staining were 
performed after 30 minutes of 0.2% (w/v) hyaluronidase digestion at 37 °C and 1 hour blocking 
with 5% BSA in PBS with 1:200 diluted mouse anti-collagen 1 (Abcam #ab6308) and 1:200 
diluted rabbit anti-collagen 2 (Rockland 600-401-104). Proteoglycan staining was performed 
after reducing the tissue with 10mM dithiothreitol in TBS pH 7.4 for 2 hours at 37ºC and 
alkylating with 40 mM iodoacetamide in PBS for 2 hours at 37°C. Sections were then digested 
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with 0.02 U/ml chondroitinase ABC for 40 minutes at 37°C and blocked for 1 hour at room 
temperature with 5% BSA before incubating with primary antibody (Hybridoma 12/21/1-C-6). 
All primary antibodies were diluted in 1% (w/v) BSA in PBS and incubated overnight at 4°C. 
Alexa Fluor 594 Goat Anti-Mouse IgG (Invitrogen, A11005), Alexa Fluor 488 Goat anti-rabbit 
Alexa 488 (Invitrogen A11008) and Alexa Fluor 488 Goat anti-mouse (Invitrogen A11029) 
secondary antibodies were used at 1:200 dilution in 1% BSA in PBS for 1 hour at RT. Finally, 
slides were incubated for 10 minutes with the nuclear stain DAPI (Molecular Probes, Invitrogen) 
before mounting with VectaMount AQ Mounting Medium (Vector Laboratories). 
RNA extraction and PCR: Samples were frozen in liquid nitrogen and crushed using pellet 
pestles (Thomas Scientific). Total RNA was prepared using NucleoSpin miRNA kit (Macherey-
Nagel) and concentration was determined with a microplate reader Synergy H1 (BioTek 
Instruments). RNA with an absorbance ratio at 260/280 nm between 1.9 and 2.1 was used for 
PCR analysis. The Fast SYBR Green Master Mix (Applied Biosystems) was used to perform the 
PCR amplification with 150 nM forward and reverse primer. All primers (see Table 1) were 
designed across exon-exon junctions using Real Time PCR Design Tool from Integrated DNA 
Technologies (http://eu.idtdna.com/Scitools/Applications/RealTimePCR/Default.asp) to avoid 
the amplification of genomic DNA. All data came from 3 independent replicates and was 
analyzed using the 2-∆∆Ct method 
31
 and normalized against the reference gene RPL13a 
32
 with 
day 0 samples chosen as reference. 
 
 
Table 1  Primer specification used for RT–PCR 
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mRNA Accession n° BP  Primer sequence (5’-3’) 
hRPL13a NM_012423 100 FWD AAGTACCAGGCAGTGACAG 
   REV CCTGTTTCCGTAGCCTCATG 
hCol1a1 NM_000088 83 FWD CAGCCGCTTCACCTACAGC 
   REV TTTTGTATTCAATCACTGTCGCC 
hCol2a1 NM_001844 92 FWD GGAATTCGGTGTGGACATAGG 
   REV ACTTGGGTCCTTTGGGTTTG 
hCol10a1 NM_000493 108 FWD ATTCCTAGTGGCTCCAATGTG 
   REV GCCTACCTCCATATGCATTTT 
hACAN NM_ 001135.3 98 FWD GAATGGGAACCAGCCTATACC 
   REV TCTGTACTTTCCTCTGTTGCTG 
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Supplementary figures showing hCCs in MMP sensitive HA-TG as well as additional physical 
and chemical characterization of HA-TG available free of charge via the Internet at 
http://pubs.acs.org. 
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New hyaluronan-based hydrogels cross-linked with the transglutaminase factor XIII, together 
with human chondroprogenitor cells, are used for cartilage tissue engineering. The gels are 
injectable, adhere to cartilage, keep encapsulated cells highly viable, retain their shape and 
promote cell proliferation and chondrogenesis. Initially soft gels with cells reach a stiffness of 
the same order of magnitude as native cartilage after 3 weeks of culture. 
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